{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:06:21Z","timestamp":1770966381269,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.beem.2023.101844","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T23:01:49Z","timestamp":1701126109000},"page":"101844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Inherited fibroblast growth factor 23 excess"],"prefix":"10.1016","volume":"38","author":[{"given":"Kripa Elizabeth","family":"Cherian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas Vizhalil","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.beem.2023.101844_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4248\/BR201302002","article-title":"FGF23 and phosphate wasting disorders","volume":"1","author":"Huang","year":"2013","journal-title":"Bone Res"},{"issue":"4","key":"10.1016\/j.beem.2023.101844_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.mnh.0000232885.81142.83","article-title":"Klotho as a regulator of fibroblast growth factor signaling and phosphate\/calcium metabolism","volume":"15","author":"Kuro-o","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7120","key":"10.1016\/j.beem.2023.101844_bib3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.beem.2023.101844_bib4","doi-asserted-by":"crossref","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","article-title":"FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1","volume":"297","author":"Gattineni","year":"2009","journal-title":"Am J Physiol Ren Physiol"},{"issue":"12","key":"10.1016\/j.beem.2023.101844_bib5","article-title":"FGF23 and vitamin D metabolism","volume":"5","author":"Latic","year":"2021","journal-title":"JBMR"},{"issue":"3","key":"10.1016\/j.beem.2023.101844_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1210\/er.2017-00220","article-title":"X-linked hypophosphatemia and FGF23-related hypophosphatemic diseases: prospect for new treatment","volume":"39","author":"Kinoshita","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2023.101844_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2016.10.015","article-title":"Genetic diseases resulting from disordered FGF23\/klotho biology","volume":"100","author":"Econs","year":"2017","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.beem.2023.101844_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"10.1016\/j.beem.2023.101844_bib9","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1210\/jcem.86.8.7761","article-title":"Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets","volume":"86","author":"Holm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101844_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.688309","article-title":"X-linked hypophosphatemic rickets: multisystemic disorder in children requiring multidisciplinary management","volume":"12","author":"Baroncelli","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2023.101844_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.866170","article-title":"Persistent lower limb deformities despite amelioration of rickets in X-linked hypophosphatemia (XLH) - a prospective observational study","volume":"13","author":"Mindler","year":"2022","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101844_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5395\/rde.2017.42.2.146","article-title":"Dental management of patients with X-linked hypophosphatemia","volume":"42","author":"Lee","year":"2017","journal-title":"Restor Dent Endod"},{"issue":"10","key":"10.1016\/j.beem.2023.101844_bib13","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00198-021-05997-1","article-title":"Burden of disease and clinical targets in adult patients with X-linked hypophosphatemia. A comprehensive review","volume":"32","author":"Giannini","year":"2021","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.beem.2023.101844_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-022-02452-0","article-title":"Health-related quality of life of X-linked hypophosphatemia in Spain","volume":"17","author":"Yanes","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.beem.2023.101844_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bone.2012.11.012","article-title":"Autosomal dominant hypophosphatemic rickets in an 85 year old woman: characterization of her disease from infancy through adulthood","volume":"52","author":"Seton","year":"2013","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.beem.2023.101844_bib16","first-page":"305","article-title":"Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation","volume":"55","author":"Kruse","year":"2001","journal-title":"Horm Res"},{"issue":"16","key":"10.1016\/j.beem.2023.101844_bib17","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.3390\/ijerph18168771","article-title":"Autosomal dominant hypophosphatemic rickets: a case report and review of the literature","volume":"18","author":"Mameli","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.beem.2023.101844_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/jbmr.3941","article-title":"Oral iron for prevention and treatment of rickets and osteomalacia in autosomal dominant hypophosphatemia","volume":"35","author":"H\u00f6gler","year":"2020","journal-title":"J Bone Min Res"},{"issue":"2","key":"10.1016\/j.beem.2023.101844_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jbmr.3878","article-title":"Oral iron replacement normalizes fibroblast growth factor 23 in iron-deficient patients with autosomal dominant hypophosphatemic rickets","volume":"35","author":"Imel","year":"2020","journal-title":"J Bone Min Res"},{"issue":"4","key":"10.1016\/j.beem.2023.101844_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00198-020-05649-w","article-title":"Iron deficiency plays essential roles in the trigger, treatment, and prognosis of autosomal dominant hypophosphatemic rickets","volume":"32","author":"Liu","year":"2021","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.beem.2023.101844_bib21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00223-019-00597-y","article-title":"Earlier onset in autosomal dominant hypophosphatemic rickets of R179 than R176 mutations in fibroblast growth factor 23: report of 20 Chinese cases and review of the literature","volume":"105","author":"Liu","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"10.1016\/j.beem.2023.101844_bib22","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00223-020-00755-7","article-title":"Clinical characteristics and bone features of autosomal recessive hypophosphatemic rickets type 1 in three Chinese families: report of five Chinese cases and review of the literature","volume":"107","author":"Ni","year":"2020","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2023.101844_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116111","article-title":"Autosomal recessive hypophosphatemic rickets type 2 (ARHR2) due to ENPP1-deficiency","volume":"153","author":"H\u00f6ppner","year":"2021","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.beem.2023.101844_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11914-017-0370-3","article-title":"Inherited arterial calcification syndromes: etiologies and treatment concepts","volume":"15","author":"Nitschke","year":"2017","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"10.1016\/j.beem.2023.101844_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jbspin.2004.05.014","article-title":"Deficiencies of physiologic calcification inhibitors and low-grade inflammation in arterial calcification: lessons for cartilage calcification","volume":"72","author":"Rutsch","year":"2005","journal-title":"Jt Bone Spine"},{"issue":"7","key":"10.1016\/j.beem.2023.101844_bib26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.tibs.2019.01.010","article-title":"ENPP1 in the regulation of mineralization and beyond","volume":"44","author":"Roberts","year":"2019","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"10.1016\/j.beem.2023.101844_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s12881-018-0593-x","article-title":"A case of Raine syndrome presenting with facial dysmorphy and review of literature","volume":"19","author":"Sheth","year":"2018","journal-title":"BMC Med Genet"},{"issue":"9","key":"10.1016\/j.beem.2023.101844_bib28","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/jmg.26.9.572","article-title":"Osteoglophonic dysplasia","volume":"26","author":"Beighton","year":"1989","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.beem.2023.101844_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/427956","article-title":"Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation","volume":"76","author":"White","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.beem.2023.101844_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0037-1602816","article-title":"Osteoglophonic dysplasia: phenotypic and radiological clues","volume":"6","author":"Kuthiroly","year":"2017","journal-title":"J Pedia Genet"},{"issue":"1","key":"10.1016\/j.beem.2023.101844_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF01644343","article-title":"Osteoglophonic dwarfism","volume":"10","author":"Beighton","year":"1980","journal-title":"Pedia Radio"},{"issue":"11","key":"10.1016\/j.beem.2023.101844_bib32","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1210\/jc.2016-2054","article-title":"Jansen metaphyseal chondrodysplasia due to heterozygous H223R-PTH1R mutations with or without overt hypercalcemia","volume":"101","author":"Nampoothiri","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2023.101844_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jc.2008-0220","article-title":"Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen\u2019s metaphyseal chondrodysplasia","volume":"94","author":"Brown","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2023.101844_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jc.2008-0220","article-title":"Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia","volume":"94","author":"Brown","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2023.101844_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11914-013-0144-5","article-title":"Fibrous dysplasia and fibroblast growth factor-23 regulation","volume":"11","author":"Boyce","year":"2013","journal-title":"Curr Osteoporos Rep"},{"issue":"5","key":"10.1016\/j.beem.2023.101844_bib36","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jbmr.1546","article-title":"Mechanism of FGF23 processing in fibrous dysplasia","volume":"27","author":"Bhattacharyya","year":"2012","journal-title":"J Bone Min Res"},{"issue":"5","key":"10.1016\/j.beem.2023.101844_bib37","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1530\/EJE-19-0969","article-title":"Diagnosis of endocrine disease: mosaic disorders of FGF23 excess: fibrous dysplasia\/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome","volume":"182","author":"de Castro","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.beem.2023.101844_bib38","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1007\/s00198-016-3702-8","article-title":"Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment","volume":"27","author":"Ovejero","year":"2016","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.beem.2023.101844_bib39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaad.2015.11.012","article-title":"Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy","volume":"75","author":"Lim","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.beem.2023.101844_bib40","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa242","article-title":"Enthesopathy, osteoarthritis, and mobility in X-linked hypophosphatemia1","volume":"105","author":"Imel","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2023.101844_bib41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1210\/clinem\/dgac488","article-title":"Approach to hypophosphatemic rickets","volume":"108","author":"Ackah","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2023.101844_bib42","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect"},{"key":"10.1016\/j.beem.2023.101844_bib43","article-title":"Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH)","volume":"103S","author":"Rothenbuhler","year":"2020","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.beem.2023.101844_bib44","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI72829","article-title":"Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia","volume":"124","author":"Carpenter","year":"2014","journal-title":"J Clin Invest"},{"issue":"21","key":"10.1016\/j.beem.2023.101844_bib45","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"issue":"10189","key":"10.1016\/j.beem.2023.101844_bib46","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2023.101844_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ghir.2017.08.001","article-title":"Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR)","volume":"36","author":"Rothenbuhler","year":"2017","journal-title":"Growth Horm IGF Res"},{"issue":"12","key":"10.1016\/j.beem.2023.101844_bib48","doi-asserted-by":"crossref","first-page":"E2097","DOI":"10.1210\/jc.2011-0399","article-title":"Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion","volume":"96","author":"\u017divi\u010dnjak","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2023.101844_bib49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00467-017-3820-3","article-title":"Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets","volume":"33","author":"Meyerhoff","year":"2018","journal-title":"Pedia Nephrol"},{"issue":"5","key":"10.1016\/j.beem.2023.101844_bib50","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2587","article-title":"Supporting the health care transition from adolescence to adulthood in the medical home","volume":"142","author":"White","year":"2018","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.beem.2023.101844_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0039-3402804","article-title":"Health care transition of adolescents and young adults with haemophilia: the situation in Germany and the Munich experience","volume":"40","author":"Bidlingmaier","year":"2020","journal-title":"Hamostaseologie"},{"issue":"10","key":"10.1016\/j.beem.2023.101844_bib52","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1210\/JC.2015-2199","article-title":"Conventional therapy in adults with X-linked hypophosphatemia: effects on enthesopathy and dental disease","volume":"100","author":"Connor","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101844_bib53","article-title":"Asia-pacific consensus recommendations on X-linked hypophosphatemia: diagnosis, multidisciplinary management, and transition from pediatric to adult care","volume":"7","author":"Munns","year":"2023","journal-title":"JBMR"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23001185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23001185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:00:51Z","timestamp":1761498051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X23001185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1521690X23001185"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2023.101844","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inherited fibroblast growth factor 23 excess","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2023.101844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101844"}}